WHO ICTRP trial
Steroid injections or Rebamipide tablets, which is better to treat painful and…
CTRI/2022/12/048127 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2022/12/048127 |
|---|---|
| Public title | Steroid injections or Rebamipide tablets, which is better to treat painful and difficult mouth opening (OSMF) |
| Scientific title | A prospective analytical study on the efficacy of oral Rebamipide vs intralesional Triamcinolone + Hyaluronidase injection for the treatment of oral submucous fibrosis in a tertiary care hospital. - OSMF |
| Primary sponsor | Osmania Medical College |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: K135- Oral submucous fibrosis |
| Interventions | Intervention1: Rebamipide: oral, dose: 100mg TID x 28 days Control Intervention1: Triamcinolone: injection, intralesional, dose: 40mg once weekly, 4 doses Control Intervention2: Hyaluronidase: injection, intralesional, dose: 1500 IU once… |
| Registration date | Dec 14, 2022 |
| Target size | 78 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: